Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
96
-
Total 13F shares, excl. options
-
34.9M
-
Shares change
-
+13.8M
-
Total reported value, excl. options
-
$87.6M
-
Value change
-
+$36.5M
-
Put/Call ratio
-
0.38
-
Number of buys
-
58
-
Number of sells
-
-45
-
Price
-
$2.51
Significant Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q2 2023
132 filings reported holding SMMT - Summit Therapeutics Inc. - COM as of Q2 2023.
Summit Therapeutics Inc. - COM (SMMT) has 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.9M shares
.
Largest 10 shareholders include BlackRock Inc. (8.76M shares), BAKER BROS. ADVISORS LP (6.3M shares), VANGUARD GROUP INC (6.1M shares), GEODE CAPITAL MANAGEMENT, LLC (2.68M shares), STATE STREET CORP (2.25M shares), NORTHERN TRUST CORP (1.03M shares), Steward Partners Investment Advisory, LLC (600K shares), MORGAN STANLEY (592K shares), ALPS ADVISORS INC (513K shares), and Nuveen Asset Management, LLC (390K shares).
This table shows the top 96 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.